Home
Platform
Services
Brands
Locations
Careers
News
Library
Responsibility
Contact Us
Platform
Our Platform
Our Competitive Edge
Services
Preclinical Development
Clinical Development
Regulatory Affairs & Consulting
Data Sciences
Molecular Laboratory R&D Services
Microbiology and Diagnostics R&D Services
Brands
Clinglobal
About us
Our Services
Our Team
Clinvet
About us
Our Services
Our Team
Clindata
About us
Our Services
Our Team
Clinomics
About us
Our Services
Our Team
Clinaxel
Rtilab
Locations
Careers
News
Social Media
Library
Research Models
Publications
Responsibility
Our Purpose
Our Values
Corporate Responsibility
Compliance
Contact us
Efficacy of sarolaner a novel oral isoxazoline, against two common mite infestations in dogs Demodex spp and Otodectes cynotis
Home
Efficacy of sarolaner a novel oral isoxazoline, against two common mite infestations in dogs Demodex spp and Otodectes cynotis
digitalplatforms
April 24, 2025
0 Comments
File Type:
pdf
File Size:
251 KB
Categories:
Publications
Post navigation
Previous
Efficacy of orally administered fluralaner (Bravecto) or topically applied imidacloprid-moxidectin (Advocate(R)) against generalized demodicosis in dogs
Next
Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs
